SCAP and neoplasm: SCAP/SREBP signaling promotes PD-1 expression in Treg cells, and specific deletion of SCAP of Treg cells leads to an inhibition of tumor growth and an increased effectiveness of anti-PD-1 immunotherapy in mice [118].